Skip to main content
. Author manuscript; available in PMC: 2013 Dec 1.
Published in final edited form as: Drug Deliv Transl Res. 2012 Dec 1;2(6):454–462. doi: 10.1007/s13346-012-0107-x

Fig. 3.

Fig. 3

Paclitaxel exposures over 24 hours in rats bearing MNU-induced breast cancer following intravenous administration of 5 mg/kg paclitaxel in P-SSMM-VIP, P-SSMM, and commercial product Paclitaxel for injections (PXT): a) Breast cancer; b) Bone marrow. Data represent the mean ± SEM; n=4 rats/formulation/time point